These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics. Rana RM; Rampogu S; Abid NB; Zeb A; Parate S; Lee G; Yoon S; Kim Y; Kim D; Lee KW Molecules; 2020 Jul; 25(15):. PubMed ID: 32752079 [TBL] [Abstract][Full Text] [Related]
30. Identification of potential drug-like molecules for inhibition of the inflammatory activity of cyclooxygenase-2. Gurung AB; Laso A; Bhattacharjee A J Biomol Struct Dyn; 2020 Nov; 38(18):5293-5306. PubMed ID: 31779538 [TBL] [Abstract][Full Text] [Related]
31. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH). Saxena S; Durgam L; Guruprasad L J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775 [TBL] [Abstract][Full Text] [Related]
32. Lipoxygenase directed anti-inflammatory and anti-cancerous secondary metabolites: ADMET-based screening, molecular docking and dynamics simulation. Singh S; Awasthi M; Pandey VP; Dwivedi UN J Biomol Struct Dyn; 2017 Feb; 35(3):657-668. PubMed ID: 26942689 [TBL] [Abstract][Full Text] [Related]
33. Identification of Antimycobacterial Agent Using In Silico Virtual Screening, ADME Prediction, Docking, and Molecular Dynamics Simulations Approach. Tripathy S; Sahu SK; Azam MA; Jupudi S; Gupta VK; Sharma S Curr Comput Aided Drug Des; 2021; 17(6):806-816. PubMed ID: 32748754 [TBL] [Abstract][Full Text] [Related]
34. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227 [TBL] [Abstract][Full Text] [Related]
35. In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment. Zarezade V; Abolghasemi M; Rahim F; Veisi A; Behbahani M J Mol Model; 2018 Nov; 24(12):337. PubMed ID: 30415281 [TBL] [Abstract][Full Text] [Related]
36. Ligand and structure based virtual screening of chemical databases to explore potent small molecule inhibitors against breast invasive carcinoma using recent computational technologies. Agarwal S; Dixit A; Kashaw SK J Mol Graph Model; 2020 Jul; 98():107591. PubMed ID: 32234678 [TBL] [Abstract][Full Text] [Related]